文献速递血液净化与透析

透析血管通路致死性出血的临床证据与管理启示

Fatal Dialysis Vascular Access Hemorrhage.
PubMed 文献 · Am J Kidney Dis · 2017-06-30

透析血管通路出血罕见,致死事件发生率低于每1000患者年1例,易被漏报,透析中心可能十年一遇。该文汇总澳大利亚和新西兰14年间所有因血管通路出血死亡的病例及各透析中心根因分析,总结临床可用的证据与经验,认为通过恰当政策与流程,这类事件可能可预防。

要点

  • 透析血管通路致死性出血罕见但灾难性,发生率低于每1000患者年1例。
  • 此类死亡可能被低估,透析中心可能十年才遇到一次。
  • 根因分析提示,恰当政策与流程下此类事件可能可预防。

核心结论

  • 透析血管通路出血致死是罕见、灾难性但可能可预防的事件,前提是建立恰当的政策与流程。

研究设计与样本

  • 该文为基于澳大利亚和新西兰14年期间所有报告的血管通路出血死亡事件及各透析中心根因分析的综述性总结。

主要发现

  • 透析血管通路(动静脉内瘘、动静脉移植物和血管导管)出血不常见,致死事件罕见且可能被漏报。
  • 致死性出血发生率低于每1000患者年1例,透析中心可能十年才经历一次。

临床怎么用

  • 临床可借鉴各透析中心根因分析的经验,通过建立恰当政策与流程来预防血管通路致死性出血。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bleeding from dialysis vascular access (arteriovenous fistulas, arteriovenous grafts, and vascular catheters) is uncommon. Death from these bleeds is rare and likely to be under-reported, with incident rates of fewer than 1 episode for every 1,000 patient-years on dialysis, meaning that dialysis units may experience this catastrophic event only once a decade. There is an opportunity to learn from (and therefore prevent) these bleeding deaths. We reviewed all reported episodes of death due to vascular access bleeding in Australia and New Zealand over a 14-year period together with individual dialysis units' root cause analyses on each event. In this perspective, we provide a clinically useful summary of the evidence and knowledge gained from these rare events. Our conclusion is that death due to dialysis vascular access hemorrhage is an uncommon, catastrophic, but potentially preventable event if the right policies and procedures are put in place.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Jose MD, Marshall MR, Read G, et al. Fatal Dialysis Vascular Access Hemorrhage. Am J Kidney Dis. 2017. PMID: 28673467. doi:10.1053/j.ajkd.2017.05.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。